Nikhil Prasad Fact checked by:Thailand Medical News Team Apr 19, 2026 1 hour, 41 minutes ago
Medical News: A major new scientific review is shedding light on a growing health threat that many people have never even heard of—high triglycerides, a type of fat in the blood that can silently increase the risk of heart disease and even trigger life-threatening pancreatitis. Researchers are now uncovering powerful new treatments that could dramatically change how this condition is managed.
New gene-targeting therapies dramatically cut harmful triglycerides and may reduce heart and pancreatitis risks
Why High Triglycerides Matter More Than You Think
Triglycerides are a type of fat that your body uses for energy, but when levels become too high, they can cause serious harm. According to the research, millions of people worldwide have elevated triglyceride levels, often without symptoms. Over time, these fats can build up in blood vessels, increasing the risk of heart attacks, strokes, and other cardiovascular problems.
Even more alarming, extremely high levels can lead to acute pancreatitis, a sudden and painful inflammation of the pancreas that can become fatal. The condition is often linked to lifestyle factors such as poor diet, alcohol consumption, obesity, and uncontrolled diabetes.
What Causes This Dangerous Condition
The study explains that triglyceride levels are controlled by a complex system in the body involving special proteins and enzymes. When this system breaks down—due to genetics, poor lifestyle, or other illnesses—fat particles begin to accumulate in the bloodstream.
Researchers highlight that in many cases, lifestyle factors like high sugar intake, excessive alcohol, and lack of exercise play a major role. However, some individuals inherit genetic disorders that make their bodies unable to properly clear these fats, putting them at extreme risk.
Current Treatments Offer Only Limited Relief
Traditional treatments such as statins, omega-3 fatty acids, fibrates, and niacin are commonly used to reduce triglyceride levels. While these therapies can help, their effects are often modest.
For example, statins typically reduce triglycerides by only about 10 to 30 percent, while omega-3 supplements can lower levels by 20 to 60 percent depending on the dose.
Despite these options, many patients with severe conditions fail to reach safe levels, leaving them vulnerable to ongoing health risks.
New Generation Therapies Show Dramatic Results
The most exciting progress highlighted in this
Medical News report lies in a new class of precision medicines that go beyond simply lowering fat levels—they actually target the genetic and molecular “switches” that control how triglycerides are produced and cleared in the body.
One of the most promising breakthroughs involves drugs that silence specific genes linked to fat metabolism. These include antisense oligonucleotides (ASOs) and
small interfering RNA (siRNA) therapies. Instead of treating symptoms, these therapies block the production of proteins like ApoC-III, which normally slows down the body’s ability to clear triglycerides. By turning off this protein, the body can rapidly break down and remove excess fats.
For instance, the drug volanesorsen showed triglyceride reductions of over 70 percent in clinical trials involving patients with severe genetic disorders. However, it came with safety concerns such as low platelet counts. Newer drugs like olezarsen have improved on this design, offering similar fat-lowering benefits with fewer side effects and more convenient dosing schedules.
Another cutting-edge therapy, plozasiran, uses siRNA technology and has demonstrated reductions of up to 80 percent in triglyceride levels. What makes this drug particularly impressive is its long-lasting effect, allowing dosing only once every few months while still maintaining strong results.
In addition to ApoC-III inhibitors, scientists are also targeting a different pathway involving proteins called ANGPTL3. These proteins normally act as “brakes” on fat breakdown. Drugs like evinacumab and zodasiran remove this brake, allowing the body to clear triglycerides much more efficiently. Some studies have shown reductions ranging from 30 percent to over 80 percent depending on the patient group and genetic background.
There is also growing excitement around hormone-based therapies such as FGF-21 analogs. One example, pegozafermin, works by improving how the liver processes fats and reducing fat production altogether. In clinical studies, it not only lowered triglycerides by more than 50 percent but also significantly reduced liver fat—an important benefit for people with fatty liver disease.
What makes these new treatments especially important is their ability to help patients who previously had very limited options. For individuals with inherited conditions like familial chylomicronemia syndrome, where triglyceride levels can skyrocket to dangerous levels, these therapies could be life-saving.
Potential Benefits Beyond Lowering Fat Levels
What makes these new therapies particularly exciting is their potential to do more than just reduce triglycerides. Early evidence suggests they may also lower the risk of pancreatitis and improve heart health outcomes.
Some treatments have even been linked to reduced liver fat and better blood sugar control, offering hope for patients with multiple metabolic conditions.
Important Role of Lifestyle Still Remains
Despite these medical advances, researchers stress that lifestyle changes remain essential. Regular exercise, weight loss, and a balanced diet low in sugar and unhealthy fats are still the foundation of treatment.
Even a modest weight loss of 5 to 10 percent can significantly reduce triglyceride levels, highlighting the importance of everyday habits in managing this condition.
Conclusion
The findings highlight a major turning point in the fight against hypertriglyceridemia. While older treatments provide limited benefits, newer targeted therapies are delivering unprecedented reductions in blood fat levels, offering new hope for patients who previously had few options. These therapies work by addressing the root biological mechanisms of disease rather than just managing symptoms, representing a shift toward precision medicine. However, long-term safety, affordability, and accessibility remain important considerations. Ultimately, combining these breakthrough drugs with consistent lifestyle changes may offer the most effective path forward in reducing cardiovascular risks and preventing severe complications such as pancreatitis.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/8/3573
For the latest on treating high triglycerides levels, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/med-news
Share
Tweet
Share
